Home › NDC Lookup › RxCUI directory › RxCUI 2717542

1.7 ML denosumab-bnht 70 MG/ML Injection — RxCUI 2717542

Name: 1.7 ML denosumab-bnht 70 MG/ML Injection (RxCUI 2717542)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic clinical drug

RxCUI 2717542 Semantic clinical drug · SCD ● Current RxNorm concept 2 FDA products 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2717542

Official name1.7 ML denosumab-bnht 70 MG/ML Injection

Concept typeSemantic clinical drug (SCD)

RxNorm statusCurrent RxNorm concept

Also known asdenosumab-bnht 120 MG per 1.7 ML Injection; denosumab-bnht 120 MG in 1.7 ML Injection; denosumab-bnht 70 MG/ML per 1.7 ML Injection

FDA products mapped2

Package NDCs mapped2

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Denosumab Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

It treats osteoporosis in people at high risk for fracture, including postmenopausal women, men, and people on long-term steroids. It also helps build bone in men on prostate cance...
Usually once every 6 months, given under the skin by a healthcare provider. If you miss one, get it as soon as you can and your 6-month schedule restarts from then. Take your calci...
Back pain, limb pain, and muscle or joint aches are most common. Some people notice bladder infections, cold symptoms, or headaches. Call your doctor for muscle cramps or tingling,...
No dose change is needed, but advanced kidney disease or dialysis raises the risk of severe low calcium, which can be life-threatening. Your doctor should check your calcium and mi...

📖 Read our full Denosumab Injection guide →

🕸️ Concept Web — How 1.7 ML denosumab-bnht 70 MG/ML Injection Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept 1.7 ML denosumab-bnht 70 MG/ML Injection RxCUI 2717542 Semantic clinical drug · SCD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 2

The active substance itself — no strength, form, or brand attached yet.
- Denosumab 993449 IN
- Denosumab-bnht 2717527 PIN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Bomyntra 2717544 BN
Dose forms 9

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Denosumab Injection 1655915 SCDF
- Denosumab-bnht Injection 2717541 SCDFP
- Denosumab Injectable Product 1157742 SCDG
- Denosumab-bnht Injectable Product 2717529 SCDGP
- Denosumab Injection [Bomyntra] 2717547 SBDF
- Denosumab-bnht Injection [Bomyntra] 2717548 SBDFP
- Bomyntra Injectable Product 2717546 SBDG
- Injection 1649574 DF
- +1 more in this family
Clinical & branded drugs 3

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Denosumab-bnht 70 MG/ML 2717540 SCDC
- 1.7 ML denosumab-bnht 70 MG/ML Injection [Bomyntra] 2717549 SBD
- Denosumab-bnht 70 MG/ML [Bomyntra] 2717545 SBDC

Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Denosumab-bnht 70 MG/ML SCDC · 2717540
Denosumab Injection SCDF · 1655915
Denosumab-bnht Injection SCDFP · 2717541
Denosumab Injectable Product SCDG · 1157742
Denosumab-bnht Injectable Product SCDGP · 2717529

Brand-Name Concepts

1.7 ML denosumab-bnht 70 MG/ML Injection [Bomyntra] SBD · 2717549
Denosumab-bnht 70 MG/ML [Bomyntra] SBDC · 2717545
Denosumab Injection [Bomyntra] SBDF · 2717547
Denosumab-bnht Injection [Bomyntra] SBDFP · 2717548
Bomyntra Injectable Product SBDG · 2717546
Bomyntra BN · 2717544

📦 FDA Products & Package NDCs

2 products · 2 package NDCs

2 package NDCs map to RxCUI 2717542 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
65219-0670-01	1 VIAL, SINGLE-DOSE in 1 CARTON (65219-670-01) / 1.7 mL in...	BOMYNTRA	Fresenius Kabi USA, LLC	2025-06-30
65219-0672-01	1 SYRINGE, PLASTIC in 1 CARTON (65219-672-01) / 1.7 mL in 1...	BOMYNTRA	Fresenius Kabi USA, LLC	2025-06-30

Observed labelers: Fresenius Kabi USA, LLC (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.

Code	Descriptor	Mapped packages	Sources
Q5158	Inj, denosumab-bnht, 1 mg	2	CMS

⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.